Navigation Links
U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership
Date:6/20/2008

DEARBORN, Mich., June 20 /PRNewswire/ -- The United States Council for Automotive Research LLC (USCAR), whose members are Chrysler LLC, Ford Motor Company and General Motors Corporation, welcomed the addition of electric utility partners to the FreedomCAR and Fuel Partnership, as announced by the U.S. Department of Energy (DOE) today (June 20) at the Automotive Hall of Fame in Dearborn, Mich.

DTE Energy and Southern California Edison were named as new members of the Partnership by U.S. DOE Assistant Secretary of Energy Efficiency and Renewable Energy Alexander (Andy) Karsner, who said the announcement "demonstrates a shared public-private sector commitment to accelerate the research, development and deployment of Plug-in Hybrid Vehicles from the laboratory to the marketplace."

Speaking on behalf of USCAR and the U.S. automakers, Gerhard Schmidt, chief technical officer and vice president for Research and Advanced Engineering at Ford, acknowledged the importance of PHEVs, while noting they are just one of many alternative-fuel vehicles being researched and developed by the Detroit Three.

"Our production-focused research includes everything from increasingly efficient cars and trucks with advanced gasoline and clean diesel engines to hydrogen-fueled internal combustion engines and fuel cells. It also includes vehicles powered by biofuels and ethanol, hybrid-electric vehicles and, of course, plug-in hybrids. Clearly, there is no silver bullet approach," he said.

This multiple pathways approach to future transportation is at the heart of the FreedomCAR and Fuel Partnership, whose vision is a clean and sustainable transportation energy future that reduces our nation's dependence on foreign oil and minimizes regulated emissions and CO2, yet preserves freedom of mobility and vehicle choice for consumers.

At USCAR, the focus is on pre-competitive R&D that results in enabling technologies. Individually, the U.S. automakers are puttin
'/>"/>

SOURCE USCAR
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Biovail Concerned Shareholders Welcome Glass Lewis Evaluation
2. Boston Scientific Welcomes Revised Outlook From Fitch Ratings
3. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
4. Aegera Therapeutics welcomes two experienced executives to its board of directors
5. Piedmont Heart Institute Welcomes Cardiology of Georgia
6. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
7. FCP Welcomes Mark Scherling
8. BioSpace Career Fair in San Francisco Welcomes Over 1,000 Bioscience Professionals
9. Start Licensing, Inc. Welcomes FDAs Finding of Safety of Food From Cloned Animals
10. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
11. BioSpace, BioNJ and Pennsylvania Bio Welcome Over 800 Life Science Career Candidates to Biotech 2007 Career Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... a well-known optical phenomenon called thin-film interference, a ... the ability to "paint" ultra-thin coatings onto a ... making future, flexible electronic devices, creating advanced solar ... ships and spacecraft with extremely lightweight decorative logos. ... it becomes iridescent, revealing a myriad of colors ...
(Date:9/30/2014)... 30, 2014 Shimadzu Scientific Instruments ... easy-to-use and highly precise tool for measuring displacement ... elongation. With 1000-mm maximum movement distance, the DSES-1000 ... a gauge length of 10 mm. In addition, ... above 50-mm stroke and within +/- 100 µm ...
(Date:9/30/2014)... , Sept. 30, 2014  RegeneRx Biopharmaceuticals, ... announced that it has received a Canadian Patent ... Actin-Sequestering Peptides.  This patent includes claims using thymosin ... other actin-sequestering peptides for these purposes.  The patent ... RegeneRx Biopharmaceuticals, Inc. ( www.regenerx.com ) ...
(Date:9/30/2014)... 2014  KemPharm, Inc., a clinical-stage specialty pharmaceutical ... proprietary new molecular entity (NME) prodrugs, announced today ... (USPTO) issued U.S. Patent No. 8,816,083 to KemPharm ... Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of ... The patent, which extends through 2032, ...
Breaking Biology Technology:Taking thin films to the extreme 2Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2
... Europe Aviation is very proud to receive its accreditation," ... "For more than 10 years our vision in the ... and BAR) has been to operate in a safe ... in France as well as facilities in East Europe, ...
... progress of plant-derived insulin program, scheduled to ... TSX symbol: SBS, CALGARY, July 29 /PRNewswire-FirstCall/ ... a portfolio of therapeutic,proteins for metabolic and cardiovascular ... New Drug (IND) application for,safflower-produced recombinant human insulin ...
... First Fully-Automated Random Access ... AACC Meeting, SUNNYVALE, Calif., July 29 ... Infinity-48 high-throughput system,at the 2008 American Association ... The newest addition to Cepheid,s GeneXpert family ...
Cached Biology Technology:First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies 2First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies 3First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies 4SemBioSys submits IND for safflower-produced insulin to U.S. FDA 2SemBioSys submits IND for safflower-produced insulin to U.S. FDA 3Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 2Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 3Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 4
(Date:9/30/2014)... New England Journal of Medicine reports positive results ... crizotinib against the subset of lung cancer marked by ... of 50 patients with advanced non-small cell lung cancer ... was 72 percent, with 3 complete responses and 33 ... takes for the disease to resume its growth after ...
(Date:9/30/2014)... in urban and farm runoff in Hawaii is causing ... , The study, published Tuesday in the peer-reviewed ... the runoff ends up in algae that the turtles ... eyes, flippers and internal organs. , Scientists at Duke ... and Atmospheric Administration (NOAA) conducted the study to better ...
(Date:9/30/2014)... want your doctor to know what goes wrong with your ... idea to know what "normal" actually is. That,s where a ... the FASEB Journal comes in. In ... key set of molecules that can help scientists "see" which ... What,s more, they found never-before-detected gene activity and that men ...
Breaking Biology News(10 mins):NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Scientists identify which genes are active in muscles of men and women 2
... and zanamivir, are highly effective when given as ... the influenza virus, according to an analysis of ... Research Center, University of Michigan and University of ... the American Journal of Epidemiology. The analysis also ...
... for granted when it is carried out by the ... when scientists devise new ways for molecules to self ... , Researchers with the Macromolecules and Interfaces Institute (MII ... development in the online issue for the Journal of ...
... Center have identified a subgroup of hard-to-treat breast cancers ... used in the treatment of breast tumors. They ... which may help identify patients most likely to benefit ... in a clinical trial anticipated to begin at the ...
Cached Biology News:Antivirals effectively curb influenza virus 2Antivirals effectively curb influenza virus 3Molecular signature may identify cisplatin-sensitive breast tumors 2Molecular signature may identify cisplatin-sensitive breast tumors 3
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to KLH (Keyhole Limpet Hemocyanin) lysine through amide bonds....
Estrogen Receptor (ER) Competitor Assay Kits Green for Estrogen Receptors-alpha and -beta (ER-Alpha and ER-Beta) are ideal for screening novel estrogen receptor binding compounds and endocrine disrup...
Human Aminopeptidase P2/XPNPEP2 Affinity Purified PAb ENTREZ GeneID: 7512...
in vitro Translation, Accessory Products...
Biology Products: